Drug · DIN 02439689
IBUPROFEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 17, 2021; first marketed December 23, 2015.
- Drug Identification Number (DIN)
- 02439689
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ibuprofen M01AE01
- Class
- Human
- Record last updated
- January 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IBUPROFEN | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 18, 2020: NOC 24251Supplement to an Abbreviated New Drug Submission (SANDS) · Safety updtate to the product monograph. labelling updates to comply with the plain language labelling requirements for ibuprofen
- April 28, 2015: NOC 16852New Drug Submission (NDS) · Additional product name
Other DINs named IBUPROFEN
- DIN 02238004 · Cancelled Post Market
- DIN 02242408 · Cancelled Post Market
- DIN 02247118 · Cancelled Post Market
- DIN 02263777 · Cancelled Pre Market
- DIN 02268760 · Cancelled Pre Market
- DIN 02309459 · Dormant
- DIN 02395169 · Approved
- DIN 02439697 · Dormant
- DIN 02439700 · Approved
- DIN 02498200 · Cancelled Pre Market
- DIN 02498219 · Cancelled Pre Market